Retraction: Zhu et al. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Frontiers in Bioscience (Landmark Edition). 2020; 25: 699–709

Frontiers in Bioscience-Landmark Editorial Office

Frontiers in Bioscience-Landmark ›› 2025, Vol. 30 ›› Issue (3) : 39230

PDF (178KB)
Frontiers in Bioscience-Landmark ›› 2025, Vol. 30 ›› Issue (3) :39230 DOI: 10.31083/FBL39230
Retraction
retraction
Retraction: Zhu et al. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Frontiers in Bioscience (Landmark Edition). 2020; 25: 699–709
Author information +
History +
PDF (178KB)

Cite this article

Download citation ▾
Frontiers in Bioscience-Landmark Editorial Office. Retraction: Zhu et al. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Frontiers in Bioscience (Landmark Edition). 2020; 25: 699–709. Frontiers in Bioscience-Landmark, 2025, 30(3): 39230 DOI:10.31083/FBL39230

登录浏览全文

4963

注册一个新账户 忘记密码

The Editor-in-Chief has retracted the article entitled “[Resveratrol reverts Streptozotocin-induced diabetic nephropathy]” [1] due to significant concerns regarding the reliability and integrity of the data presented.
Recently, several issues were brought to the attention of the Publisher and Editor-in-Chief regarding the originality and authenticity of the images in this paper published in 2020 prior to the present publisher and EiC taking over the management of the journal. The content of repeated figures includes but is not limited to:
Fig. 2B contains images that are identical to those in Fig. 5F of a previously published paper [2].
Fig. 2B contains images that are identical to those in Fig. 5D of a previously published paper [3].
Fig. 3C contains images that are identical to those in Fig. 4A of a previously published paper [4].
On being contacted, the authors conceded that there were errors in their article and requested that it be retracted. The Editor-in-Chief is unable to retrospectively determine how these errors arose, and therefore after careful consideration and in accordance with the publication’s ethical guidelines, has decided to agree to the authors’ request to retract the article. All authors agree to this retraction.

References

[1]

Zhu H, Zhong S, Yan H, Wang K, Chen L, Zhou M, et al. Resveratrol reverts Streptozotocin-induced diabetic nephropathy. Frontiers in Bioscience (Landmark Edition). 2020; 25: 699–709. https://doi.org/10.2741/4829.

[2]

Cui H, Ren G, Hu X, Xu B, Li Y, Niu Z, et al. Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo. Renal Failure. 2022; 44: 1070–1082. https://doi.org/10.1080/0886022X.2022.2092001.

[3]

Zhengbiao Z, Liang C, Zhi Z, Youmin P. Circular RNA_HIPK3-Targeting miR-93-5p Regulates KLF9 Expression Level to Control Acute Kidney Injury. Computational and Mathematical Methods in Medicine. 2023; 2023: 1318817. https://doi.org/10.1155/2023/1318817.

[4]

Li L, Liu JD, Gao GD, Zhang K, Song YW, Li HB. Puerarin 6″-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K/AKT/mTOR. Cancer Medicine. 2020; 9: 6399–6410. https://doi.org/10.1002/cam4.3285. Retraction in: Cancer Medicine. 2024; 13: e70301. https://doi.org/doi:10.1002/cam4.70301.

PDF (178KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/